Novel Coronavirus (COVID-2019) update: Please refer to the Centers for Disease Control and Prevention (CDC) website, www.cdc.gov/coronavirus

Symposium on

Exosomes and Other Extracellular Vesicles
November 02, 2020


Philip W. Askenase

Philip W. Askenase

Yale University School of Medicine, CT, USA

Title: Suppressor T-cell Exosome miRNA-150 Induces APC To Release Ag/MHCpos Secondary Suppressive Exosomes, Binding TCR at the Immune Synapse to Inhibit DTH Effector T-cells

Raghu Kalluri

Raghu Kalluri

The University of Texas MD Anderson Cancer Center, TX, USA

Title: TBD

Kendall D. Hirschi

Kendall D. Hirschi

Baylor College of Medicine, TX, USA

Title: Impact of a Plant-Based Dietary miRNA on the Gut Microbiome

Joost J. Oppenheim

Joost J. Oppenheim

NCI/CCR, NIH
MD, USA

Title: Oncolytic Reagents may also Enhance Anti-Tumor Immunity by Inducing MyD88-dependent Maturation of Dendritic Cells

Scott K. Durum

Scott K. Durum

NCI/CCR, NIH
MD, USA

Title: TBA

Guido Kroemer

Guido Kroemer

Gustave Roussy Comprehensive Cancer Center, INSERM, France

Title: Overcoming a frequent inborn immune defect in breast cancer therapy

Lauren V. Wood

Lauren V. Wood

Chief Medical Officer, PDS Biotechnology, NJ

Title: Versamune (R-D0TAP): a Transformative Cationic Lipid Nanoparticle Technology Associated with Type I Interferon Specific Activation and Generation of Antibody, CD8 and CD4 T Cell Responses to Recombinant Proteins and Peptide Tumor Antigens

Wayne Godfrey

Wayne Godfrey

Vice President of Clinical Development at IGM Bioscience

Title: Novel Approach to Engineering Antibody Based Immunotherapy

Eduardo Davila

Eduardo Davila

University of Colorado CU Comprehensive Cancer Center, CO

Title: Novel Gene Platforms to Maintain the Persistence and Antitumor Activity of TIL-, CAR-, and DC-Based Therapies

Shannon Lauberth

William Hearl

Ph.D. CEO, Immunomic Therapeutics, MD

Title: UNITE Platform, A Direct Antigen Presentation Approach in Oncology

Brian Francica

Brian Francica

Tempest Therapeutics, CA

Title: Dual Antagonism of Prostaglandin Receptors EP2 and EP4 by TPST-1495 Suppresses Tumor Growth and Stimulates Antitumor Immunity

Jing H. Wang

Jing H. Wang

University of Colorado Anschutz Medical Campus, CO

Title: MHC Class-I Independent Activation of Virtual- Memory CD8 T Cells Induced by Chemotherapeutic Agent-Treated Cancer Cells

Jing H. Wang

Pooja Jain

Drexel University College of Medicine, Philadelphia, PA

Title: The MAPK/ERK-regulated MEF-2 isoforms as potential new target(s) for HTLV-1 induced Adult T-cell leukemia/lymphoma (ATLL)

Jing H. Wang

Jason D. Marshall

Leidos Biomedical Research, Inc., NCI Campus at Frederick, MD

Title: Performance Optimization of a Novel HPV VLP Vaccine in Mice with Novel Adjuvants

Joseph Markowitz

Joseph Markowitz

Moffit Cancer Center, FL

Title: Duality of NO in Melanoma

Jean Gariepy

Jean Gariepy

Sunnybrook Research Institute, Toronto, Canada

Title: Development of high-valency protein-based agonists as immunomodulators

Yan Leyfmann

Yan Leyfmann

Penn State College of Medicine, PA

Title: Finetune Your CARs: Building the Next Generation of Anti-Cancer Therapies

Jessica E. Thaxton

Jessica E. Thaxton

Medical University of South Carolina, SC

Title: Metabolic Requirements for T Cell Protein Translation in Tumors

Theresa L. Whiteside

Theresa L. Whiteside

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center, PA

Title: Tumor-Derived Exosomes and Their Role in Cancer Progression

Session on

Immune Modulation and Autoimmunity


Stephen D. Miller

Stephen D. Miller

Northwestern University Medical School, IL, USA

Title: Translation of a Nanoparticle-Based Delivery System for the Induction of Immune Tolerance

David Wagner

David Wagner

University of Colorado at Denver, CO, USA

Title: Exploring the role of CD40 in Autoimmune Inflammation: Impact on Disease

Pamela A. Guerrerio

Pamela A. Guerrerio

NCI/CCR, NIH
MD, USA

Title: Tgfbr1-Mediated Defects in Squamous Epithelium Drive Local Allergic Inflammation

Session on

Immune Defense: Cellular and Molecular Response Regulation


Warren J. Leonard

Warren J. Leonard

NHLBI, NIH
MD, USA

Title: TBA

Patricia Gearhart

Patricia Gearhart

NHLBI, NIH
MD, USA

Title: B Cells in Aging

Jacques Robert

Jacques Robert

University of Rochester Medical Center, NY

Title: Roles of Non-polymorphic MHC and innate T cells in antimycobacterial immune response and tolerance.

About the Meeting

Immunology is one of the areas with the most cutting-edge and state of the art research going on in almost every corner of the world. This conference aims to bring together people from various areas of research and development in immunology in order to help grow and create opportunities for further advances in the field.

The program will not only include renowned keynote speakers who helped shape the turn of the century concepts in immunity and immunology but also young academicians with diverse approaches to age-old conceptions in immunology. We hope to encourage dialogue between all the attendees in order to fill in the gaps to inspire innovative collaborations in:

This Virtual Conference is a platform free of hurdles associated with:

  • Immunotherapy in Cancer
  • Basic Immunity and Immune Defense
  • Immune Regulation and Autoimmunity
  • Allergy and Hypersensitivity
  • Virology and Vaccine Development
  • Antibody Therapeutics
  • Symposium on Exosomes and other Extracellular Vesicles

Immunology Meeting 2019 Gallery

ichem
ichem
ichem
ichem
ichem
ichem
ichem
ichem

Subscribe and get our news and updates.